NCT02141282 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- All-cause mortality reported from enrollment to 30 d after last dose of study drug; median time on follow up was up to 1694 d for those with ibrutinib-resistant or refractory CLL and up to 1942 d for those with idelalisib-resistant or refractory CLL. TEAEs and SAEs collected from first dose of study drug until 30 d after last dose of study drug; mean duration on study drug was 819.8 d (ibrutinib-resistant or refractory CLL cohorts) and 1151.5 d (idelalisib-resistant or refractory CLL cohorts).
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| ABT-199 After Ibrutinib Therapy: Main Cohort | 35 / 43 | 43 / 43 | 25 / 43 |
| ABT-199 After Idelalisib Therapy: Main Cohort | 14 / 21 | 21 / 21 | 9 / 21 |
| ABT-199 After Ibrutinib or Idelalisib Therapy: Main Cohort | 49 / 64 | 64 / 64 | 34 / 64 |
| ABT-199 After Ibrutinib Therapy: Expansion Cohort | 26 / 48 | 48 / 48 | 17 / 48 |
| ABT-199 After Idelalisib Therapy: Expansion Cohort | 9 / 15 | 15 / 15 | 4 / 15 |
| ABT-199 After Ibrutinib or Idelalisib Therapy: Expansion Cohort | 35 / 63 | 63 / 63 | 21 / 63 |
| ABT-199 After Ibrutinib Therapy: Main and Expansion Cohorts | 61 / 91 | 91 / 91 | 42 / 91 |
| ABT-199 After Idelalisib Therapy: Main and Expansion Cohorts | 23 / 36 | 36 / 36 | 13 / 36 |
| All Participants | 84 / 127 | 127 / 127 | 55 / 127 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 2
- term
- ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 91
- num Events
- 3
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 3
- term
- AUTOIMMUNE HAEMOLYTIC ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 43
- num Events
- 13
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 11
- num At Risk
- 64
- num Events
- 14
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 48
- num Events
- 4
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 63
- num Events
- 4
- group Id
- EG006
- num Affected
- 13
- num At Risk
- 91
- num Events
- 17
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 14
- num At Risk
- 127
- num Events
- 18
- term
- FEBRILE NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- HAEMOLYTIC ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- LYMPHOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- THROMBOCYTOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- ANGINA UNSTABLE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 2
- term
- ATRIAL FIBRILLATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- ATRIAL FLUTTER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- CARDIAC FAILURE CONGESTIVE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 91
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 2
- term
- MYOCARDIAL INFARCTION
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 24
- num At Risk
- 43
- num Events
- 44
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 21
- num Events
- 25
- group Id
- EG002
- num Affected
- 28
- num At Risk
- 64
- num Events
- 69
- group Id
- EG003
- num Affected
- 21
- num At Risk
- 48
- num Events
- 51
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 3
- group Id
- EG005
- num Affected
- 24
- num At Risk
- 63
- num Events
- 54
- group Id
- EG006
- num Affected
- 45
- num At Risk
- 91
- num Events
- 95
- group Id
- EG007
- num Affected
- 7
- num At Risk
- 36
- num Events
- 28
- group Id
- EG008
- num Affected
- 52
- num At Risk
- 127
- num Events
- 123
- term
- ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 3
- num At Risk
- 91
- num Events
- 3
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 4
- num At Risk
- 127
- num Events
- 4
- term
- LYMPH NODE PAIN
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 43
- num Events
- 32
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 21
- num Events
- 27
- group Id
- EG002
- num Affected
- 26
- num At Risk
- 64
- num Events
- 59
- group Id
- EG003
- num Affected
- 20
- num At Risk
- 48
- num Events
- 44
- group Id
- EG004
- num Affected
- 9
- num At Risk
- 15
- num Events
- 15
- group Id
- EG005
- num Affected
- 29
- num At Risk
- 63
- num Events
- 59
- group Id
- EG006
- num Affected
- 36
- num At Risk
- 91
- num Events
- 76
- group Id
- EG007
- num Affected
- 19
- num At Risk
- 36
- num Events
- 42
- group Id
- EG008
- num Affected
- 55
- num At Risk
- 127
- num Events
- 118
- term
- NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 11
- num At Risk
- 43
- num Events
- 14
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 21
- num Events
- 24
- group Id
- EG002
- num Affected
- 17
- num At Risk
- 64
- num Events
- 38
- group Id
- EG003
- num Affected
- 14
- num At Risk
- 48
- num Events
- 25
- group Id
- EG004
- num Affected
- 4
- num At Risk
- 15
- num Events
- 7
- group Id
- EG005
- num Affected
- 18
- num At Risk
- 63
- num Events
- 32
- group Id
- EG006
- num Affected
- 25
- num At Risk
- 91
- num Events
- 39
- group Id
- EG007
- num Affected
- 10
- num At Risk
- 36
- num Events
- 31
- group Id
- EG008
- num Affected
- 35
- num At Risk
- 127
- num Events
- 70
- term
- THROMBOCYTOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 4
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 6
- num At Risk
- 127
- num Events
- 6
- term
- ABDOMINAL DISCOMFORT
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 64
- num Events
- 3
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 48
- num Events
- 5
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 63
- num Events
- 7
- group Id
- EG006
- num Affected
- 8
- num At Risk
- 91
- num Events
- 8
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 10
- num At Risk
- 127
- num Events
- 10
- term
- ABDOMINAL DISTENSION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 43
- num Events
- 10
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 64
- num Events
- 10
- group Id
- EG003
- num Affected
- 13
- num At Risk
- 48
- num Events
- 16
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 5
- group Id
- EG005
- num Affected
- 16
- num At Risk
- 63
- num Events
- 21
- group Id
- EG006
- num Affected
- 20
- num At Risk
- 91
- num Events
- 26
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 36
- num Events
- 5
- group Id
- EG008
- num Affected
- 23
- num At Risk
- 127
- num Events
- 31
- term
- ABDOMINAL PAIN
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 64
- num Events
- 3
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 48
- num Events
- 3
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 4
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 63
- num Events
- 7
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 5
- group Id
- EG007
- num Affected
- 4
- num At Risk
- 36
- num Events
- 5
- group Id
- EG008
- num Affected
- 8
- num At Risk
- 127
- num Events
- 10
- term
- ABDOMINAL PAIN UPPER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 43
- num Events
- 12
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 21
- num Events
- 7
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 64
- num Events
- 19
- group Id
- EG003
- num Affected
- 17
- num At Risk
- 48
- num Events
- 18
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 4
- group Id
- EG005
- num Affected
- 20
- num At Risk
- 63
- num Events
- 22
- group Id
- EG006
- num Affected
- 24
- num At Risk
- 91
- num Events
- 30
- group Id
- EG007
- num Affected
- 10
- num At Risk
- 36
- num Events
- 11
- group Id
- EG008
- num Affected
- 34
- num At Risk
- 127
- num Events
- 41
- term
- CONSTIPATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 43
- num Events
- 38
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 21
- num Events
- 18
- group Id
- EG002
- num Affected
- 31
- num At Risk
- 64
- num Events
- 56
- group Id
- EG003
- num Affected
- 26
- num At Risk
- 48
- num Events
- 56
- group Id
- EG004
- num Affected
- 8
- num At Risk
- 15
- num Events
- 15
- group Id
- EG005
- num Affected
- 34
- num At Risk
- 63
- num Events
- 71
- group Id
- EG006
- num Affected
- 48
- num At Risk
- 91
- num Events
- 94
- group Id
- EG007
- num Affected
- 17
- num At Risk
- 36
- num Events
- 33
- group Id
- EG008
- num Affected
- 65
- num At Risk
- 127
- num Events
- 127
- term
- DIARRHOEA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 21
- num Events
- 3
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 64
- num Events
- 5
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 48
- num Events
- 5
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 63
- num Events
- 5
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 91
- num Events
- 7
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 36
- num Events
- 3
- group Id
- EG008
- num Affected
- 10
- num At Risk
- 127
- num Events
- 10
- term
- DRY MOUTH
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 4
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 5
- num At Risk
- 127
- num Events
- 6
- term
- DYSPEPSIA
Complete source fields
- event Groups
- deaths Num Affected
- 25
- deaths Num At Risk
- 43
- description
- Participants with ibrutinib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Main Cohort
- id
- EG000
- other Num Affected
- 43
- other Num At Risk
- 43
- serious Num Affected
- 35
- serious Num At Risk
- 43
- title
- ABT-199 After Ibrutinib Therapy: Main Cohort
- deaths Num Affected
- 9
- deaths Num At Risk
- 21
- description
- Participants with idelalisib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Main Cohort
- id
- EG001
- other Num Affected
- 21
- other Num At Risk
- 21
- serious Num Affected
- 14
- serious Num At Risk
- 21
- title
- ABT-199 After Idelalisib Therapy: Main Cohort
- deaths Num Affected
- 34
- deaths Num At Risk
- 64
- description
- Participants with ibrutinib-resistant/refractory or idelalisib-resistant/refractory chronic lymphocytic leukemia (CLL) in the Main Cohort
- id
- EG002
- other Num Affected
- 64
- other Num At Risk
- 64
- serious Num Affected
- 49
- serious Num At Risk
- 64
- title
- ABT-199 After Ibrutinib or Idelalisib Therapy: Main Cohort
- deaths Num Affected
- 17
- deaths Num At Risk
- 48
- description
- Participants with ibrutinib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Expansion Cohort
- id
- EG003
- other Num Affected
- 48
- other Num At Risk
- 48
- serious Num Affected
- 26
- serious Num At Risk
- 48
- title
- ABT-199 After Ibrutinib Therapy: Expansion Cohort
- deaths Num Affected
- 4
- deaths Num At Risk
- 15
- description
- Participants with idelalisib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Expansion Cohort
- id
- EG004
- other Num Affected
- 15
- other Num At Risk
- 15
- serious Num Affected
- 9
- serious Num At Risk
- 15
- title
- ABT-199 After Idelalisib Therapy: Expansion Cohort
- deaths Num Affected
- 21
- deaths Num At Risk
- 63
- description
- Participants with ibrutinib-resistant/refractory or idelalisib-resistant/refractory chronic lymphocytic leukemia (CLL) in the Expansion Cohort
- id
- EG005
- other Num Affected
- 63
- other Num At Risk
- 63
- serious Num Affected
- 35
- serious Num At Risk
- 63
- title
- ABT-199 After Ibrutinib or Idelalisib Therapy: Expansion Cohort
- deaths Num Affected
- 42
- deaths Num At Risk
- 91
- description
- Participants with ibrutinib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Main and Expansion Cohorts
- id
- EG006
- other Num Affected
- 91
- other Num At Risk
- 91
- serious Num Affected
- 61
- serious Num At Risk
- 91
- title
- ABT-199 After Ibrutinib Therapy: Main and Expansion Cohorts
- deaths Num Affected
- 13
- deaths Num At Risk
- 36
- description
- Participants with idelalisib-resistant or refractory chronic lymphocytic leukemia (CLL) in the Main and Expansion Cohorts
- id
- EG007
- other Num Affected
- 36
- other Num At Risk
- 36
- serious Num Affected
- 23
- serious Num At Risk
- 36
- title
- ABT-199 After Idelalisib Therapy: Main and Expansion Cohorts
- deaths Num Affected
- 55
- deaths Num At Risk
- 127
- description
- All participants in the Main and Expansion Cohorts
- id
- EG008
- other Num Affected
- 127
- other Num At Risk
- 127
- serious Num Affected
- 84
- serious Num At Risk
- 127
- title
- All Participants
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 24
- num At Risk
- 43
- num Events
- 44
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 21
- num Events
- 25
- group Id
- EG002
- num Affected
- 28
- num At Risk
- 64
- num Events
- 69
- group Id
- EG003
- num Affected
- 21
- num At Risk
- 48
- num Events
- 51
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 3
- group Id
- EG005
- num Affected
- 24
- num At Risk
- 63
- num Events
- 54
- group Id
- EG006
- num Affected
- 45
- num At Risk
- 91
- num Events
- 95
- group Id
- EG007
- num Affected
- 7
- num At Risk
- 36
- num Events
- 28
- group Id
- EG008
- num Affected
- 52
- num At Risk
- 127
- num Events
- 123
- term
- ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 3
- num At Risk
- 91
- num Events
- 3
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 4
- num At Risk
- 127
- num Events
- 4
- term
- LYMPH NODE PAIN
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 43
- num Events
- 32
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 21
- num Events
- 27
- group Id
- EG002
- num Affected
- 26
- num At Risk
- 64
- num Events
- 59
- group Id
- EG003
- num Affected
- 20
- num At Risk
- 48
- num Events
- 44
- group Id
- EG004
- num Affected
- 9
- num At Risk
- 15
- num Events
- 15
- group Id
- EG005
- num Affected
- 29
- num At Risk
- 63
- num Events
- 59
- group Id
- EG006
- num Affected
- 36
- num At Risk
- 91
- num Events
- 76
- group Id
- EG007
- num Affected
- 19
- num At Risk
- 36
- num Events
- 42
- group Id
- EG008
- num Affected
- 55
- num At Risk
- 127
- num Events
- 118
- term
- NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 11
- num At Risk
- 43
- num Events
- 14
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 21
- num Events
- 24
- group Id
- EG002
- num Affected
- 17
- num At Risk
- 64
- num Events
- 38
- group Id
- EG003
- num Affected
- 14
- num At Risk
- 48
- num Events
- 25
- group Id
- EG004
- num Affected
- 4
- num At Risk
- 15
- num Events
- 7
- group Id
- EG005
- num Affected
- 18
- num At Risk
- 63
- num Events
- 32
- group Id
- EG006
- num Affected
- 25
- num At Risk
- 91
- num Events
- 39
- group Id
- EG007
- num Affected
- 10
- num At Risk
- 36
- num Events
- 31
- group Id
- EG008
- num Affected
- 35
- num At Risk
- 127
- num Events
- 70
- term
- THROMBOCYTOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 4
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 6
- num At Risk
- 127
- num Events
- 6
- term
- ABDOMINAL DISCOMFORT
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 64
- num Events
- 3
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 48
- num Events
- 5
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 63
- num Events
- 7
- group Id
- EG006
- num Affected
- 8
- num At Risk
- 91
- num Events
- 8
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 10
- num At Risk
- 127
- num Events
- 10
- term
- ABDOMINAL DISTENSION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 43
- num Events
- 10
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 64
- num Events
- 10
- group Id
- EG003
- num Affected
- 13
- num At Risk
- 48
- num Events
- 16
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 5
- group Id
- EG005
- num Affected
- 16
- num At Risk
- 63
- num Events
- 21
- group Id
- EG006
- num Affected
- 20
- num At Risk
- 91
- num Events
- 26
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 36
- num Events
- 5
- group Id
- EG008
- num Affected
- 23
- num At Risk
- 127
- num Events
- 31
- term
- ABDOMINAL PAIN
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 64
- num Events
- 3
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 48
- num Events
- 3
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 4
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 63
- num Events
- 7
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 5
- group Id
- EG007
- num Affected
- 4
- num At Risk
- 36
- num Events
- 5
- group Id
- EG008
- num Affected
- 8
- num At Risk
- 127
- num Events
- 10
- term
- ABDOMINAL PAIN UPPER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 43
- num Events
- 12
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 21
- num Events
- 7
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 64
- num Events
- 19
- group Id
- EG003
- num Affected
- 17
- num At Risk
- 48
- num Events
- 18
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 15
- num Events
- 4
- group Id
- EG005
- num Affected
- 20
- num At Risk
- 63
- num Events
- 22
- group Id
- EG006
- num Affected
- 24
- num At Risk
- 91
- num Events
- 30
- group Id
- EG007
- num Affected
- 10
- num At Risk
- 36
- num Events
- 11
- group Id
- EG008
- num Affected
- 34
- num At Risk
- 127
- num Events
- 41
- term
- CONSTIPATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 43
- num Events
- 38
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 21
- num Events
- 18
- group Id
- EG002
- num Affected
- 31
- num At Risk
- 64
- num Events
- 56
- group Id
- EG003
- num Affected
- 26
- num At Risk
- 48
- num Events
- 56
- group Id
- EG004
- num Affected
- 8
- num At Risk
- 15
- num Events
- 15
- group Id
- EG005
- num Affected
- 34
- num At Risk
- 63
- num Events
- 71
- group Id
- EG006
- num Affected
- 48
- num At Risk
- 91
- num Events
- 94
- group Id
- EG007
- num Affected
- 17
- num At Risk
- 36
- num Events
- 33
- group Id
- EG008
- num Affected
- 65
- num At Risk
- 127
- num Events
- 127
- term
- DIARRHOEA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 21
- num Events
- 3
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 64
- num Events
- 5
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 48
- num Events
- 5
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 63
- num Events
- 5
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 91
- num Events
- 7
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 36
- num Events
- 3
- group Id
- EG008
- num Affected
- 10
- num At Risk
- 127
- num Events
- 10
- term
- DRY MOUTH
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 43
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 64
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 91
- num Events
- 4
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 5
- num At Risk
- 127
- num Events
- 6
- term
- DYSPEPSIA
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 2
- term
- ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 91
- num Events
- 3
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 3
- term
- AUTOIMMUNE HAEMOLYTIC ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 43
- num Events
- 13
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG002
- num Affected
- 11
- num At Risk
- 64
- num Events
- 14
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 48
- num Events
- 4
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 63
- num Events
- 4
- group Id
- EG006
- num Affected
- 13
- num At Risk
- 91
- num Events
- 17
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 14
- num At Risk
- 127
- num Events
- 18
- term
- FEBRILE NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- HAEMOLYTIC ANAEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- LYMPHOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- NEUTROPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- THROMBOCYTOPENIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 91
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- ANGINA UNSTABLE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 2
- term
- ATRIAL FIBRILLATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- ATRIAL FLUTTER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 43
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 64
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 48
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 91
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 127
- num Events
- 1
- term
- CARDIAC FAILURE CONGESTIVE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 24.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 43
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 64
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 48
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 91
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 36
- num Events
- 0
- group Id
- EG008
- num Affected
- 2
- num At Risk
- 127
- num Events
- 2
- term
- MYOCARDIAL INFARCTION
- time Frame
- All-cause mortality reported from enrollment to 30 d after last dose of study drug; median time on follow up was up to 1694 d for those with ibrutinib-resistant or refractory CLL and up to 1942 d for those with idelalisib-resistant or refractory CLL. TEAEs and SAEs collected from first dose of study drug until 30 d after last dose of study drug; mean duration on study drug was 819.8 d (ibrutinib-resistant or refractory CLL cohorts) and 1151.5 d (idelalisib-resistant or refractory CLL cohorts).
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle